Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal

Biochemical and Biophysical Research Communications

Volumn 361, Issue 3, 2007, Pages 763-767

  Yang, Huirong ^a   Chen, Jian ^b   Yang, Jingchun ^a   Qiao, Shouyi ^a   Zhao, Shouyuan ^a   Yu, Long ^a  

^a FUDAN UNIVERSITY   (China)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

c Jun NH2 terminal kinase; Cyclophilin A; ERK1 2; p38 kinase; Small cell lung carcinoma

Indexed keywords

CD147 ANTIGEN; CYCLOPHILIN A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDYLPROLYL ISOMERASE; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL GROWTH; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG CANCER; LUNG SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTIGENS, CD147; CARCINOMA, SMALL CELL; CYCLOPHILIN A; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PEPTIDYLPROLYL ISOMERASE; TIME FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 34547808171     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.07.085     Document Type: Article

References (22)

1. Farmer G. Targeted lung cancer therapies. Nat. Rev. Drug. Discov. 548 (2004) 547-548
2. Schuller H.M. Mechanisms of smoking related lung and pancreatic adenocarcinoma development. Nat. Rev. 2 (2002) 455-463
3. Howard B.A., Furumai R., Campa M.J., Rabbani Z.N., Vujaskovic Z., Wang X.F., and Patz Jr. E.F. Stable RNA interference-mediated suppression of Cyclophilin A diminishes non-small cell lung tumor growth in vivo. Cancer Res. 65 (2005) 8853-8860
4. Yang H., Li M., Chai H., Yan S.Y., Lin P., Lumsden A.B., Yao Q.Z., and Chen C.Y. Effects of Cyclophilin A on cell proliferation and gene expressions in human vascular smooth muscle cells and endothelial cells. J. Surg. Res. 123 (2005) 312-319
5. Campa M.J., Wang M.Z., Howard B., Fitzgerald M.C., and Patz Jr. E.F. Protein expression profiling identifies macrophage migration inhibitory factor and Cyclophilin A as potential molecular targets in non-small cell lung cancer. Cancer Res. 63 (2003) 1652-1656
6. Li M., Zhai Q.H., Bharadwaj U., Wang H., Li F., and Fisher W.E. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 106 (2006) 2284-2294
7. Nishida E., and Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci. 18 (1993) 128-131
8. Avruch J., Zhang X.F., and Kyriakis J.M. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem. Sci. 19 (1994) 279-283
9. Davis R.J. MAPKs: new JNK expands the group. Trends Biochem. Sci. 19 (1994) 470-473
10. Iwasaki S., Hattori A., Sato M., Tsujimoto M., and Kohno M. Characterization of the bone morphogenetic protein-2 as a neurotrophic factor. J. Biol. Chem. 271 (1996) 17360-17365
11. Iwasaki S., Iguchi M., Watanabe K., Hoshino R., Tsujimoto M., and Kohno M. Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC12 cells by bone morphogenetic protein-2. J. Biol. Chem. 274 (1999) 26503-26510
12. Schwenger P., Alpert D., Skolnik E.Y., and Vilcek J. Cell-type-specific activation of c-Jun N-terminal kinase by salicylates. Mol. Cell. Biol. 18 (1998) 78-84
13. Cobb M.H., and Goldsmith E.J. How MAP kinases are regulated. J. Biol. Chem. 270 (1995) 14843-14846
14. Zydowsky L.D., Etzkorn F.A., Chang H.Y., Ferguson S.B., Stolz L.A., Ho S.I., and Walsh C.T. Active site mutants of human Cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition. Protein Sci. 1 (1992) 1092-1099
15. Jin Z.G., Lungu A.O., Xie L., Wang M., Wong C., and Berk B.C. Cyclophilin A Is a Proinflammatory Cytokine that Activates Endothelial Cells. Arterioscler Thromb. Vasc. Biol. 24 (2004) 1186-1191
16. Gothel S.F., and Marahiel M.A. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cell. Mol. Life Sci. 55 (1999) 423-436
17. Braaten D., and Luban J. Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO J. 20 (2001) 1300-1309
18. Jin Z.G., Melaragno M.G., Liao D.F., Yan C., Haendeler J., Suh Y.A., Lambeth J.D., and Berk B.C. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res. 87 (2000) 789-796
19. Bennetta P.C., Singaretnam L.G., Zhao W.Q., Lawenb A., and Ng K.T. Peptidyl-prolyl-cis/trans-isomerase activity may be necessary for memory formation. FEBS Lett. 431 (1998) 386-390
20. Zhu P., Ding J., Zhou J., Dong W.J., Fan C.M., and Chen Z.N. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production. Arthritis Res. Ther. 7 (2005) 1023-1033
21. Nahreini P., Hovland A.R., Kumar B., Andreatta C., Edwards-Prasad J., and Prasad K.N. Effects of altered Cyclophilin A expression on growth and differentiation of human and mouse neuronal cells. Cell. Mol. Neurobiol. 21 (2001) 739-745
22. Hong F., Lee J., Song J.W., Lee S.J., Ahn H., Je J., Ha C., and Kim S.S. Cyclosporine blocks muscle differentiation by inducing oxidative stress and by inhibiting the peptidylprolyl-cis-trans-isomerase activity of Cyclophilin A: Cyclophilin A protects myoblasts from cyclosporine-induced cytotoxicity. FASEB J. 16 (2002) 1633-1635